Wenqian Zhang

Wenqian Zhang

Auto-generated profile, based on publicly available information

Wenqian Zhang

Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2021 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
WZWenqian Zhang
Wenqian Zhang
CWChaojie Wang
Chaojie Wang
SLShenrong Liu
Shenrong Liu
LZLingmei Zhou
Lingmei Zhou
JLJunjie Li
Junjie Li
ZZZhiwei Zhang
Zhiwei Zhang
Background. With the rapid development of transcatheter techniques and instruments, transcatheter occlusion for patients with perimembranous ventricular septal defect (pVSD) and aortic valve prolapse (AVP) was constantly being tried, while the efficacy and safety of pVSD with AVP remain controversial. Objective. The aim of this study was to evaluate long-term efficacy and safety of transcatheter occlusion of pVSD with AVP. Methods. We retrospectively analyzed 164 children with pVSD and AVP who underwent transcatheter occlusion between January 2013 and November 2014. AVP was divided into 3 degrees according to right coronary leaflet morphology at end-diastole during aortic root angiography. Patient demographic and clinical data were collected. Results. There were 97 males and 67 females (median age, 40.0 (30.062.7) months; average weight, 16.94±9.02kg). Mild (n=63), moderate (n=89), and severe (n=12) AVP success rates were 93.7, 89.9, and 58.3, respectively. Immediately after procedure, there was no new-onset aortic regurgitation (AR) above trivial degree, residual shunt above mild degree, or complications requiring medication or operation, except for 1 patient who developed transient complete atrioventricular block. During follow-up, 1 mild AVP patient aggravated from mild to moderate AR and 1 moderate AVP patient aggravated from trivial to moderate AR. The new-onset AR in mild, moderate, and severe AVP was 2, 1.8, and 20, respectively. AR disappeared in 17 patients. Residual shunt occurred in 9 patients after procedure, 4 of which disappeared during the follow-up period. No serious complications occurred in any patient during follow-up. Five-year cardiovascular event-free survival rates for mild, moderate, and severe AVP were 89.6, 94.5, and 80.0, respectively. Conclusion. Transcatheter occlusion of pVSD with mild and moderate AVP has a high success rate and few complications, which is safe and effective in long-term follow-up. Transcatheter occlusion of pVSD with severe AVP has low success rates and high AR incidence. Therefore, transcatheter occlusion of pVSD with AVP is recommended for mild to moderate, but not severe, AVP.

11 September 2021 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
PDF file
SLShenrong Liu
Shenrong Liu
WZWenqian Zhang
Wenqian Zhang
JLJunjie Li
Junjie Li
SWShushui Wang
Shushui Wang
MQMingyang Qian
Mingyang Qian
ZZZhiwei Zhang
Zhiwei Zhang
Background. Transcatheter closure of aneurysmal perimembranous ventricular septal defect (pmVSD), pmVSD near the aortic valve, and intracristal VSD (icVSD) with symmetrical or asymmetrical ventricular septal defect occluders still presents significant challenges. We report our experience with transcatheter closure of pmVSD and icVSD using Amplatzer duct occluder II (ADO II) in children. Method. We retrospectively analyzed all children, who presented to our hospital consecutively between March 2014 and June 2020 for attempted transcatheter closure of pmVSD or icVSD with the ADO II device. Standard safety and last-follow-up outcomes were assessed and compared. Results. In total, 41 patients underwent transcatheter closure of VSD with the ADO II (28 in pmVSD and 13 in icVSD groups) with a median age of 3.5 years (total range: 0.9 to 12 years) and median weight of 15.0kg (total range: 10.0 to 43.0kg). Implantation was successful in 40/41 patients (97.5, 27/28 in pmVSD group, 13/13 in icVSD group). One patient with mild aortic valve prolapse in pmVSD group developed new-onset moderate aortic regurgitation after a 4/4mm ADO II was deployed; however, this resolved after the device was retrieved and successfully replaced with a 5mm zero eccentric VSD occluder. There was no procedure-related mortality. After a median follow-up of six months (total range: 6 to 72 months), complete closure rates were 85.1 and 76.9 among pmVSD and icVSD groups, respectively. In the pmVSD group, one case of new-onset moderate tricuspid regurgitation was observed at six months, and there was one case of severe tricuspid regurgitation that had progressed from mild tricuspid regurgitation at 12 months. No serious complications were noted in the icVSD group. Conclusion. ADO II provides a safe and reproducible alternative for the closure of perimembranous and intracristal ventricular septal defects with a diameter less than 5mm in young children.

1 January 2024 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
CWChaojie Wang
Chaojie Wang
WZWenqian Zhang
Wenqian Zhang
GWGe Wang
Ge Wang
ZZZengxiao Zou
Zengxiao Zou
MCMan Chen
Man Chen
XFXiao ping Fan
Xiao ping Fan
Wang C, et al. Korean Circ J. 2024 Sep;54:e104. https://doi.org/10.4070/kcj.2024.0219

20 November 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
ZZZengxiao Zou
Zengxiao Zou
CWChaojie Wang
Chaojie Wang
WZWenqian Zhang
Wenqian Zhang
ZWZhixiong Wu
Zhixiong Wu
RZRongjun Zou
Rongjun Zou
Xiaoping FanXiaoping Fan
Xiaoping Fan
Acute type A aortic dissection involving the aortic sinus is often combined with varying degrees of aortic regurgitation, while the structure of the aortic valve is often undamaged. The aim of this study was to evaluate the clinical effects of reconstruction of the aortic sinus using patches in patients with acute type A aortic dissection. From January 2016 to December 2019, 52 patients with acute type A aortic dissection involving the aortic sinus were treated with aortic sinus reconstruction using pericardial or artificial vascular patches. The clinical and follow-up data were summarized. Bovine pericardial patches were used in 31 cases and artificial vascular patches were used in 21 cases for aortic sinus reconstruction. Cardiopulmonary bypass time was (250.4 ± 65.7) min, aortic cross clamp time was (143.7 ± 42.3) min, and hypothermic circulatory arrest time was (9.6 ± 8.1) min. Three patients died in hospital, with a mortality rate of 5.8%. Fifteen patients (28.8%) had mild postoperative aortic regurgitation. The follow-up duration was 40 ± 12 (range, 21-66) months. Five patients (10.2%) developed moderate to severe aortic regurgitation and 3 (6.1%) died during the follow-up period. The application of patches for aortic sinus reconstruction is a relatively easy method in aortic valve-sparing root reconstruction for acute type A aortic dissection involving the aortic sinus. The clinical and follow-up results are favorable.